Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Patent
1997-10-07
1999-06-15
Tsang, Cecilia J.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
530418, 530364, 530380, 530383, 435239, A23G 100
Patent
active
059123281
ABSTRACT:
In order to separate viruses from protein solutions, particles of a solid phase are suspended in said protein solution. The solid phase is an adsorbent chosen from the group kieselguhr, silicic acid, clay minerals, metal hydroxide or oxihydrate, cellulose, perlite, and water insoluble synthetic polymers. Subsequently the solid phase together with the viruses that have adsorbed to it is separated from the fluid phase. The protein solution is brought into contact at least once with the solid phase for at least 10 minutes during which time a suspension is formed; subsequently the solid phase is separated from the liquid phase.
REFERENCES:
patent: 4156681 (1979-05-01), Schneider et al.
patent: 4305870 (1981-12-01), Liu et al.
patent: 5051189 (1991-09-01), Farrah
patent: 5658779 (1997-08-01), Krupey et al.
Dahling and Wright, "A comparison of recovery of virus from wastewaters by beef extract-Celite, ferric chloride, and filter concentration procedures, " Journal of Virological Methods 22: 337-346, 1988.
Elodi et al., "Double Virus Inactivated F VIII Concentrate: Virus Validation and Clinical Efficacy of Haemoctin.RTM. (Biotest F VIII SDH), " Animals of Hematology, Supplement I70: 137, 1995.
Farrah et al., "Use of Modified Diatomaceous Earth for Removal and Recovery of Viruses in Water," Applied and Environmental Microbiology 57(9): 2502-2506, 1991.
Labedan, B., "In Vitro Study of the Phage T5 DNA Injection Process: Use of Columns of Escherichia coli Membranes Immobilized on Kieselguhr," Virology 85: 487-493, 1978.
Morgenthaler, J.-J., (eds)., Current Studies in Hematology and Blood Transfusion No. 56: Virus Inactivation in Plasma Products, Karger, New York, 1989.
Piszkiewicz et al., "Inactivation and Removal of Human Immunodeficiency Virus in Monoclonal Purified Antihemophilic Factor (Human) (Hemofil.RTM.M)," Thrombosis Research 55: 627-634, 1989.
Preston and Farrah, "Activation Thermodynamics of Virus Adsorption to Solids," Applied and Enviromental Microbiology 54(11): 2650-2654, 1988.
Wells et al., "Inactivation and partition of human T-cell lymphotropic virus, type III, during ethanol fractionation of plasma," Transfusion 26(2): 210-213, 1986.
Satlar et al., Water Res., 13(7), 637-43, 1979.
Lawrence, A., Symp. Ser. Immunobiol. Stand., 7, 217-26, 1967.
Globa et al., Dopov. Akad. Nauk Ukr. RSR, Ser. B, 3(11), 1036-8, 1971.
Stephan et al., Z. Klin. Chem. Klin. Biochem., 6(3), 191-2, 1968.
Morgenthaler Jean-Jacques
Omar Adames
Delacroix-Muirheid C.
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst
Tsang Cecilia J.
LandOfFree
Method for the removal of viruses from protein solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the removal of viruses from protein solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the removal of viruses from protein solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-403324